Home › Free Stock Grades › NEOG
Neogen Corporation (NEOG) Stock Grade
NEOG · Healthcare
C+
Market Cap
$1.3B
P/E Ratio
—
Revenue Growth (YoY)
-3.2%
Net Margin
-122.1%
Return on Equity
—
Dividend Yield
None
About Neogen Corporation's fundamentals
Neogen Corporation, a diagnostics and research company with a $1.3 billion market cap, is currently unprofitable with a net margin of -122.1% and reported a net loss in its latest annual statement. The company's revenue declined 3.2% year-over-year, indicating contraction in its top line during this period. With no dividend payment and negative profitability metrics, Neogen is in a loss-making position and not yet generating shareholder returns through distributions.